证券之星消息,贝达药业(300558)02月04日在投资者关系平台上答复投资者关心的问题。投资者提问:据公开信息,公司多次提到布局ADC产品项目。请问董秘,这是自研产品还是从生态圈战略合作伙伴引进?贝达药业回复:您好!公司自研尚未有ADC产品项目立项,将通过生态圈联动合作伙伴积极关注ADC产品项目,后续如有相关重大节点进展,公司会及时公开披露。谢谢!为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。
证券之星消息,贝达药业(300558)02月04日在投资者关系平台上答复投资者关心的问题。投资者提问:据公开信息,公司多次提到布局ADC产品项目。请问董秘,这是自研产品还是从生态圈战略合作伙伴引进?贝达药业回复:您好!公司自研尚未有ADC产品项目立项,将通过生态圈联动合作伙伴积极关注ADC产品项目,后续如有相关重大节点进展,公司会及时公开披露。谢谢!为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.